{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T13:52:29Z","timestamp":1780321949748,"version":"3.54.1"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1093\/jac\/dkt136","type":"journal-article","created":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T21:25:52Z","timestamp":1367443552000},"page":"2092-2098","source":"Crossref","is-referenced-by-count":37,"title":["Consequences of revised CLSI and EUCAST guidelines for antibiotic susceptibility patterns of ESBL- and AmpC \u03b2-lactamase-producing clinical Enterobacteriaceae isolates"],"prefix":"10.1093","volume":"68","author":[{"given":"Michael","family":"Hombach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brice","family":"Mouttet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido V.","family":"Bloemberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,4,30]]},"reference":[{"key":"key\n\t\t\t\t20170511115139_DKT136C1","doi-asserted-by":"crossref","first-page":"pii=19044","DOI":"10.2807\/ese.13.47.19044-en","article-title":"Increasing prevalence of ESBL-producing Enterobacteriaceae in Europe","volume":"13","author":"Coque","year":"2008","journal-title":"Euro Surveill"},{"key":"key\n\t\t\t\t20170511115139_DKT136C2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/jac\/dkq388","article-title":"Trends in production of extended-spectrum \u03b2-lactamases among Enterobacteriaceae of clinical interest: results of a nationwide survey in Belgian hospitals","volume":"66","author":"Rodriguez-Villalobos","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170511115139_DKT136C3","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2165\/11533040-000000000-00000","article-title":"Infections with extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae: changing epidemiology and drug treatment choices","volume":"70","author":"Pitout","year":"2010","journal-title":"Drugs"},{"key":"key\n\t\t\t\t20170511115139_DKT136C4","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1128\/AAC.50.4.1257-1262.2006","article-title":"Clinical and economic impact of bacteremia with extended-spectrum-\u03b2-lactamase-producing Enterobacteriaceae","volume":"50","author":"Schwaber","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170511115139_DKT136C5","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1128\/AAC.01509-06","article-title":"Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-\u03b2-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment","volume":"51","author":"Tumbarello","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170511115139_DKT136C6","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ijantimicag.2009.01.009","article-title":"Risk factors and clinical features of infections caused by plasmid-mediated AmpC \u03b2-lactamase-producing Enterobacteriaceae","volume":"34","author":"Park","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"key\n\t\t\t\t20170511115139_DKT136C7","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1128\/CMR.18.4.657-686.2005","article-title":"Extended-spectrum \u03b2-lactamases: a clinical update","volume":"18","author":"Paterson","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"key\n\t\t\t\t20170511115139_DKT136C8","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1086\/421094","article-title":"Population-based laboratory surveillance for Escherichia coli\u2013producing extended-spectrum \u03b2-lactamases: importance of community isolates with blaCTX-M genes","volume":"38","author":"Pitout","year":"2004","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170511115139_DKT136C9","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1086\/508877","article-title":"Bacteremia due to extended-spectrum \u03b2-lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge","volume":"43","author":"Rodriguez-Bano","year":"2006","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170511115139_DKT136C10","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1128\/CMR.00036-08","article-title":"AmpC \u03b2-lactamases","volume":"22","author":"Jacoby","year":"2009","journal-title":"Clin Microbiol Rev"},{"key":"key\n\t\t\t\t20170511115139_DKT136C11","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1128\/AAC.49.1.358-365.2005","article-title":"Molecular characterization of cefoxitin-resistant Escherichia coli from Canadian hospitals","volume":"49","author":"Mulvey","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170511115139_DKT136C12","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1128\/JCM.00091-11","article-title":"Detection of AmpC \u03b2-lactamase in Escherichia coli: comparison of three phenotypic confirmation assays and genetic analysis","volume":"49","author":"Peter-Getzlaff","journal-title":"J Clin Microbiol;"},{"key":"key\n\t\t\t\t20170511115139_DKT136C13","author":"EUCAST","year":"2013"},{"key":"key\n\t\t\t\t20170511115139_DKT136C14","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1469-0691.2011.03703.x","article-title":"EUCAST expert rules in antimicrobial susceptibility testing","volume":"19","author":"Leclercq","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20170511115139_DKT136C15","volume-title":"Clinical Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Nineteenth Informational Supplement M100-S19","year":"2009"},{"key":"key\n\t\t\t\t20170511115139_DKT136C16","volume-title":"Clinical Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Twenty-third Informational Supplement M100-S23","year":"2013"},{"key":"key\n\t\t\t\t20170511115139_DKT136C17","volume-title":"Expert Rules in Antimicrobial Susceptibility Testing","author":"EUCAST","year":"2008"},{"key":"key\n\t\t\t\t20170511115139_DKT136C18","volume-title":"Breakpoint Tables for Interpretation of MICs and Zone Diameters","author":"EUCAST","year":"2010"},{"key":"key\n\t\t\t\t20170511115139_DKT136C19","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1111\/j.1469-0691.2011.03737.x","article-title":"Evaluation of a diagnostic flow chart for detection and confirmation of extended spectrum \u03b2-lactamases (ESBL) in Enterobacteriaceae","volume":"18","author":"Polsfuss","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t20170511115139_DKT136C20","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1128\/JCM.00404-11","article-title":"Practical approach for reliable detection of AmpC \u03b2-lactamase-producing Enterobacteriaceae","volume":"49","author":"Polsfuss","year":"2011","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20170511115139_DKT136C21","doi-asserted-by":"crossref","first-page":"3318","DOI":"10.1128\/JCM.00756-06","article-title":"Prevalence of newer \u03b2-lactamases in gram-negative clinical isolates collected in the United States from 2001 to 2002","volume":"44","author":"Moland","year":"2006","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20170511115139_DKT136C22","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1128\/JCM.40.6.2153-2162.2002","article-title":"Detection of plasmid-mediated AmpC \u03b2-lactamase genes in clinical isolates by using multiplex PCR","volume":"40","author":"Perez-Perez","year":"2002","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20170511115139_DKT136C23","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1093\/jac\/45.6.783","article-title":"Analysis of the effects of \u221242 and \u221232 ampC promoter mutations in clinical isolates of Escherichia coli hyperproducing AmpC","volume":"45","author":"Caroff","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170511115139_DKT136C24","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1128\/JCM.00222-11","article-title":"Susceptibility of extended-spectrum-\u03b2-lactamase-producing Enterobacteriaceae according to the new CLSI breakpoints","volume":"49","author":"Wang","year":"2011","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t20170511115139_DKT136C25","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1093\/jac\/dks088","article-title":"Are susceptibility tests enough, or should laboratories still seek ESBLs and carbapenemases directly?","volume":"67","author":"Livermore","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170511115139_DKT136C26","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1128\/CMR.00061-10","article-title":"Expert systems in clinical microbiology","volume":"2b4","author":"Winstanley","year":"2011","journal-title":"Clin Microbiol Rev"},{"key":"key\n\t\t\t\t20170511115139_DKT136C27","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/jac\/dkl483","article-title":"CTX-M: changing the face of ESBLs in Europe","volume":"59","author":"Livermore","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170511115139_DKT136C28","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1128\/AAC.01591-05","article-title":"Outer membrane protein changes and efflux pump expression together may confer resistance to ertapenem in Enterobacter cloacae","volume":"50","author":"Szabo","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170511115139_DKT136C29","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1099\/jmm.0.008094-0","article-title":"Reduced susceptibility to carbapenems in Klebsiella pneumoniae clinical isolates associated with plasmid-mediated \u03b2-lactamase production and OmpK36 porin deficiency","volume":"58","author":"Wang","year":"2009","journal-title":"J Med Microbiol"},{"key":"key\n\t\t\t\t20170511115139_DKT136C30","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ijantimicag.2006.11.020","article-title":"Ertapenem resistance among Klebsiella and Enterobacter submitted in the UK to a reference laboratory","volume":"29","author":"Woodford","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"key\n\t\t\t\t20170511115139_DKT136C31","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S1473-3099(08)70041-0","article-title":"Extended-spectrum \u03b2-lactamase-producing Enterobacteriaceae: an emerging public-health concern","volume":"8","author":"Pitout","year":"2008","journal-title":"Lancet Infect Dis"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/68\/9\/2092\/16862843\/dkt136.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,15]],"date-time":"2022-02-15T19:00:10Z","timestamp":1644951610000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article-lookup\/doi\/10.1093\/jac\/dkt136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,30]]},"references-count":31,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2013,4,30]]},"published-print":{"date-parts":[[2013,9]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkt136","relation":{},"ISSN":["1460-2091","0305-7453"],"issn-type":[{"value":"1460-2091","type":"electronic"},{"value":"0305-7453","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4,30]]}}}